![Michal Sheleg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michal Sheleg
Hoofd Techniek/Wetenschap/O&O bij
PLURI INC.
Profiel
Michal Sheleg is currently working as the VP-Clinical Development at Pluri, Inc. She has been in this position since 2017.
In terms of education, Dr. Sheleg has an undergraduate degree from Saint Peter's University, a graduate degree from State University of New Jersey, and a doctorate degree from Rutgers School of Dental Medicine.
Actieve functies van Michal Sheleg
| Bedrijven | Functie | Begin |
|---|---|---|
| PLURI INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2017 |
Opleiding van Michal Sheleg
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
33
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Pluri, Inc.
 Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Saint Peter's University
 Saint Peter's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers School of Dental Medicine
 Rutgers School of Dental Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New Jersey
 State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
